RBI Defers New Capital Market, Share Loan Norms to July 1

The Reserve Bank of India (RBI) has announced a three-month deferral for the implementation of its revised guidelines concerning capital market exposures (CME) for banks, postponing the effective date from April 1, 2026, to July 1, 2026. This significant decision, communicated on March 30/31, 2026, provides banks, capital market intermediaries, and other industry stakeholders additional time to prepare for and align with the new regulatory framework. The revised directives, which were originally issued on February 13, 2026, after a comprehensive public consultation process, aim to establish a more robust and enabling environment within the financial sector. Their primary objectives are multifaceted: to provide a clear and facilitating framework for banks to finance corporate acquisitions, to rationalize the existing limits for lending by banks to individuals against shares and units of investment vehicles like REITs and InvITs, and to institute a more principle-based approach for extending credit facilities to capital market intermediaries (CMIs). One of the key components of these amended directions is the specific cap on loans against shares. The RBI has mandated that loans to individuals against shares and other eligible securities will be capped at ₹1 crore per borrower across the entire banking system. Furthermore, within this overall limit, a sub-limit of ₹25 lakh has been set for financing subscriptions to Initial Public Offerings (IPOs), Follow-on Public Offers (FPOs), and Employee Stock Ownership Plans (ESOPs). This measure aims to curb excessive speculative borrowing and mitigate risks associated with highly leveraged positions, particularly during periods of market volatility. It's important to note that the ₹1 crore limit for loans against shares was an enhancement from a previous limit of ₹20 lakh, a change that was announced earlier, around October 2025, as part of broader reforms to expand credit access and deepen capital market participation. The recent deferral pertains to the comprehensive set of capital market exposure norms which include this enhanced cap. In addition to the limits on loans against shares, the revised framework significantly addresses acquisition finance. The RBI has now provided an explicit framework allowing domestic lenders to fund corporate acquisitions by Indian companies. The definition of acquisition finance has been expanded to include mergers and amalgamations. Crucially, such financing is permitted only for acquiring control over a non-financial target company. In scenarios where acquisition finance is extended to a subsidiary or a Special Purpose Vehicle (SPV) of the acquiring company, the RBI has clarified that a corporate guarantee from the acquiring company is a mandatory requirement. Refinancing of acquisition finance is also permitted, but strictly for retiring the original acquisition debt, and only after the acquisition has been fully concluded and control of the target company established. The norms also introduce changes for credit facilities extended to Capital Market Intermediaries (CMIs). The RBI is moving towards a more principle-based framework in this area. Notably, bank financing to CMIs for proprietary trading may now be undertaken against 100% collateral, provided it comprises cash or cash equivalents. Furthermore, a previous prohibition on extending finance to market makers against securities in which market-making operations are undertaken has been removed. Clarifications were also issued regarding intraday facilities to non-debt mutual funds against same-day guaranteed receivables, stipulating that these will not be reckoned as capital market exposure under certain conditions. The primary reason for the deferral, as cited by the central bank, was the numerous representations received from various stakeholders including banks, capital market intermediaries, and industry associations. These entities sought an extension of the effective date and requested clarity on certain operational and interpretational issues related to the new regulations. Acknowledging these concerns, the RBI engaged in further discussions with stakeholders and concluded that an extension was necessary. This allows market participants sufficient time to align their internal systems, processes, and operational protocols with the revised requirements, ensuring a smoother transition and effective implementation. The implications of this deferral are significant for the Indian financial sector. While the core objectives of promoting financial stability, curbing speculative excesses, and enabling credit flow for productive purposes remain, the delay offers a temporary reprieve and an opportunity for financial institutions to adapt. For banks, this means more time to refine their risk management frameworks and internal processes. For non-banking financial companies (NBFCs), which are often active in the loan against shares and IPO financing segments, the delay allows them to adjust their business volumes and risk controls. The RBI has also eased capital adequacy norms for banks issuing irrevocable payment commitments to stock exchange clearing corporations, requiring capital only on the portion classified as capital market exposure, with an applicable risk weight of 125%. This calibrated approach by the RBI demonstrates a commitment to balancing prudent regulatory oversight with the operational realities and developmental needs of India's dynamic capital markets. Overall, the news reflects the RBI's responsive approach to industry feedback while maintaining its focus on financial stability and responsible growth within the capital markets. The deferral, therefore, is not a withdrawal of the norms but a strategic pause to ensure their effective and seamless integration into the financial ecosystem.

Frequently Asked Questions

Read Full Story on Quick Digest